ALCAM and triple-negative breast carcinoma: Previous research showed that miR-483-5p had a prometastatic function that downregulated tumor suppressors RhoGDI1 and ALCAM (activated leukocyte cell adhesion molecule) [48], inhibited miR-483-5p, and could also impede tumor proliferation in triple-negative breast cancer [49].